Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Gastroenterology|April 14, 2009
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinomaJorge A Marrero, Ziding Feng, Yinghui Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2017
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine TransaminaseJu Dong Yang, Jianliang Dai, Amit G Singal, et al.
Journal of Hepatology|June 26, 2012
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trialJordi Bruix, Jean-Luc Raoul, Morris Sherman, et al.
Hepatology Communications|December 9, 2024
Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosisHashem B El-Serag, Aaron P Thrift, Hao Duong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 23, 2016
Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational studyMasatoshi Kudo, Riccardo Lencioni, Jorge A Marrero, et al.
Journal of the American College of Radiology : JACR|November 27, 2022
ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update, Erica M Knavel Koepsel, Amanda R Smolock, et al.
International Journal of Cancer|May 21, 2021
A first-in-class, first-in-human, phase I trial of CIGB-552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF-κB in patients with advanced solid tumorsMaribel G Vallespi, Braulio Mestre, Maria A Marrero, et al.
International Journal of Clinical Practice|June 16, 2012
First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional studyR Lencioni, M Kudo, S-L Ye, et al.
Radiology|January 9, 2016
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEONJean-François Geschwind, Masatoshi Kudo, Jorge A Marrero, et al.
Journal of Hepatology|July 30, 2016
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON studyJorge A Marrero, Masatoshi Kudo, Alan P Venook, et al.
Pageof 22